Bonino F, Hoyer B, Nelson J, Engle R, Verme G, Gerin J
Hepatology. 1981 Sep-Oct;1(5):386-91. doi: 10.1002/hep.1840010503.
Sera and liver biopsies from 30 Italian patients, carriers of HBsAg for at least 3 years, were examined for markers of hepatitis B virus (HBV) infection by serological assays and immunofluorescence. Biopsies were analyzed for HBcAg, HBsAg, and delta antigen by immunofluorescence; sera were assayed for HBsAg/anti-HBs, HBcAg/anti-HBc, HBeAg/anti-HBe, delta/anti-delta, HBV-specific DNA polymerase activity and the presence of HBV DNA. HBcAg, HBeAg, and DNA polymerase tests were positive in the sera of 71, 86, and 57%, respectively, of carriers with intrahepatic HBcAg. HBV DNA was detected in 100% of patients expressing HBcAg in the liver with a strong correlation between the concentration of serum DNA and the intensity of HBcAg immunofluorescence in the liver. HBV DNA was detected in the sera of 63% of carriers with intrahepatic delta where the other markers of HBV replication (HBeAg, DNA polymerase) were undetectable. The assay for serum HBV DNA appears to be an excellent noninvasive method for detecting active replication of HBV in HBsAg carriers.
对30名携带HBsAg至少3年的意大利患者的血清和肝活检组织进行了检测,通过血清学检测和免疫荧光法检测乙型肝炎病毒(HBV)感染标志物。通过免疫荧光法分析活检组织中的HBcAg、HBsAg和δ抗原;检测血清中的HBsAg/抗-HBs、HBcAg/抗-HBc、HBeAg/抗-HBe、δ/抗-δ、HBV特异性DNA聚合酶活性以及HBV DNA的存在情况。在肝内有HBcAg的携带者血清中,HBcAg、HBeAg和DNA聚合酶检测的阳性率分别为71%、86%和57%。在肝脏中表达HBcAg的患者中,100%检测到HBV DNA,血清DNA浓度与肝脏中HBcAg免疫荧光强度之间存在很强的相关性。在肝内有δ抗原的携带者中,63%的携带者血清中检测到HBV DNA,而HBV复制的其他标志物(HBeAg、DNA聚合酶)未检测到。血清HBV DNA检测似乎是一种检测HBsAg携带者中HBV活跃复制的极佳非侵入性方法。